Human Mitochondrial NAD(P)+–Dependent Malic Enzyme Participates in Cutaneous Melanoma Progression and Invasion  Yung-Lung Chang, Hong-Wei Gao, Chien-Ping.

Slides:



Advertisements
Similar presentations
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer  Ming-Chuan Wang, PhD, Ying-Hua Chang,
Advertisements

Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
Cell Surface CD74–MIF Interactions Drive Melanoma Survival in Response to Interferon-γ  Keiji Tanese, Yuuri Hashimoto, Zuzana Berkova, Yuling Wang, Felipe.
A Signal Transduction Pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its Correlation with Progression in Human Melanoma  Xuan Qu, Liangliang Shen,
IMP-3 Promotes Migration and Invasion of Melanoma Cells by Modulating the Expression of HMGA2 and Predicts Poor Prognosis in Melanoma  Yi-Shuan Sheen,
PFKFB3, a Direct Target of p63, Is Required for Proliferation and Inhibits Differentiation in Epidermal Keratinocytes  Robert B. Hamanaka, Gökhan M. Mutlu 
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression  Dongdong Lu, Chang Han, Tong.
Deregulation of SLIT2-Mediated Cdc42 Activity Is Associated with Esophageal Cancer Metastasis and Poor Prognosis  Ruo-Chia Tseng, PhD, Jia-Ming Chang,
Jasmine George, Minakshi Nihal, Chandra K
Cdc42 Inhibits ERK-Mediated Collagenase-1 (MMP-1) Expression in Collagen-Activated Human Keratinocytes  Maryam G. Rohani, Brian K. Pilcher, Peter Chen,
Somatic Mutations in MAP3K5 Attenuate Its Proapoptotic Function in Melanoma through Increased Binding to Thioredoxin  Todd D. Prickett, Brad Zerlanko,
Up-Regulation of RFC3 Promotes Triple Negative Breast Cancer Metastasis and is Associated With Poor Prognosis Via EMT  Zhen-Yu He, San-Gang Wu, Fang Peng,
Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target  Daniel Humme, Ahmed Haider, Markus Möbs, Hiroshi.
Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R
Dual Role of Apoptosis-Associated Speck-Like Protein Containing a CARD (ASC) in Tumorigenesis of Human Melanoma  Weimin Liu, Yuchun Luo, Jeffrey H. Dunn,
Cleidson P. Alves, Milene H. Moraes, Josane F. Sousa, Carmen Lucia S
Rapamycin Suppresses Tumor Growth and Alters the Metabolic Phenotype in T-Cell Lymphoma  Wasakorn Kittipongdaja, Xuesong Wu, Justine Garner, Xiping Liu,
Cyclooxygenase-2 Overexpression in Human Basal Cell Carcinoma Cell Line Increases Antiapoptosis, Angiogenesis, and Tumorigenesis  Jeng-Wei Tjiu, Yi-Hua.
BAP1 Has a Survival Role in Cutaneous Melanoma
Sarah A. Best, Amy N. Nwaobasi, Chrysalyne D. Schmults, Matthew R
Xuesong Wu, Timothy W. Wang, George M
Decreased Expression of the Chromatin Remodeler ATRX Associates with Melanoma Progression  Zulekha A. Qadeer, Sara Harcharik, David Valle-Garcia, Chen.
Galectin-1 Accelerates Wound Healing by Regulating the Neuropilin-1/Smad3/NOX4 Pathway and ROS Production in Myofibroblasts  Yueh-Te Lin, Jhih-Sian Chen,
Epidermal Growth Factor Facilitates Melanoma Lymph Node Metastasis by Influencing Tumor Lymphangiogenesis  Andreas Bracher, Ana Soler Cardona, Stefanie.
CYLD Inhibits Melanoma Growth and Progression through Suppression of the JNK/AP-1 and β1-Integrin Signaling Pathways  Hengning Ke, Christina K. Augustine,
CCN2 Expression by Tumor Stroma Is Required for Melanoma Metastasis
Alpha-Actinin 4 Is Associated with Cancer Cell Motility and Is a Potential Biomarker in Non–Small Cell Lung Cancer  Ming-Chuan Wang, PhD, Ying-Hua Chang,
Glyoxalase I Is Differentially Expressed in Cutaneous Neoplasms and Contributes to the Progression of Squamous Cell Carcinoma  Xiao-Yan Zou, Dong Ding,
Volume 6, Issue 1, Pages (January 2014)
EIF4E Is an Adverse Prognostic Marker of Melanoma Patient Survival by Increasing Melanoma Cell Invasion  Shahram Khosravi, Kevin J. Tam, Gholamreza S.
Sensitization of Melanoma Cells for Death Ligand TRAIL Is Based on Cell Cycle Arrest, ROS Production, and Activation of Proapoptotic Bcl-2 Proteins  Sandra-Annika.
Tie2-R849W Mutant in Venous Malformations Chronically Activates a Functional STAT1 to Modulate Gene Expression  Hsiao-Tang Hu, Yi-Hsien Huang, Yi-Ann.
Transdifferentiation of Melanoma Cells by the Reprogramming Factors Attenuates Malignant Nature In Vitro and In Vivo  Mikiro Takaishi, Shigetoshi Sano 
Xuesong Wu, Timothy W. Wang, George M
Ha Linh Vu, Sheera Rosenbaum, Claudia Capparelli, Timothy J
Chantal S. Colmont, Antisar B. Ketah, Rachel J. Errington, Simon H
Rolando Perez-Lorenzo, Kamraan Z. Gill, Che-Hung Shen, Feng X
The Hematopoietic Stem Cell Regulatory Gene Latexin Has Tumor-Suppressive Properties in Malignant Melanoma  Viswanathan Muthusamy, Sanjay Premi, Cara.
Osteopontin Expression Correlates with Melanoma Invasion
TGF-β-Induced (TGFBI) Protein in Melanoma: A Signature of High Metastatic Potential  Laura Lauden, Johan Siewiera, Wahid Boukouaci, Kiran Ramgolam, Samia.
SOX4 Promotes Proliferative Signals by Regulating Glycolysis through AKT Activation in Melanoma Cells  Wei Dai, Xinyuan Xu, Shuli Li, Jingjing Ma, Qiong.
Pro-Invasive Activity of the Hippo Pathway Effectors YAP and TAZ in Cutaneous Melanoma  Flore Nallet-Staub, Véronique Marsaud, Ling Li, Cristèle Gilbert,
Volume 142, Issue 7, Pages e2 (June 2012)
Yuchun Luo, Lixia Z. Ellis, Katiuscia Dallaglio, Moe Takeda, William A
Brian Poligone, Elaine S. Gilmore, Carolina V
Integrative Functional Genomics Implicates EPB41 Dysregulation in Hepatocellular Carcinoma Risk  Xinyu Yang, Dianke Yu, Yanli Ren, Jinyu Wei, Wenting.
C/EBPγ Regulates Wound Repair and EGF Receptor Signaling
The Glutamate Release Inhibitor Riluzole Decreases Migration, Invasion, and Proliferation of Melanoma Cells  Maithao N. Le, Joseph L.-K. Chan, Stephen.
Yao Zhan, Michael S. Dahabieh, Arjuna Rajakumar, Monica C
Decreased expression of FOXA2 promotes eutopic endometrial cell proliferation and migration in patients with endometriosis  Anping Lin, Juan Yin, Chao.
Noah C. Jenkins, Jae Jung, Tong Liu, Megan Wilde, Sheri L
Somatic Mutation of GRIN2A in Malignant Melanoma Results in Loss of Tumor Suppressor Activity via Aberrant NMDAR Complex Formation  Todd D. Prickett,
GSK3β Inhibition Blocks Melanoma Cell/Host Interactions by Downregulating N- Cadherin Expression and Decreasing FAK Phosphorylation  Jobin K. John, Kim.
Yabin Cheng, Guangdi Chen, Magdalena Martinka, Vincent Ho, Gang Li 
Volume 6, Issue 1, Pages (January 2014)
Epigenetic Silencing of SPINT2 Promotes Cancer Cell Motility via HGF-MET Pathway Activation in Melanoma  Soonyean Hwang, Hye-Eun Kim, Michelle Min, Rekha.
Hermine Schlagbauer-Wadl, Marieke Griffioen, Andrea van Elsas, Peter I
Pituitary Tumor-Transforming Gene 1 Enhances Proliferation and Suppresses Early Differentiation of Keratinocytes  Yosuke Ishitsuka, Yasuhiro Kawachi,
Overexpression of the Transcription Factor Yin-Yang-1 Suppresses Differentiation of HaCaT Cells in Three-Dimensional Cell Culture  Shijima Taguchi, Yasuhiro.
The IL-6 Trans-Signaling-STAT3 Pathway Mediates ECM and Cellular Proliferation in Fibroblasts from Hypertrophic Scar  Sutapa Ray, Xiaoxi Ju, Hong Sun,
Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas  Fang Liu, Juxiang Cao, Jinxiang Wu, Kayleigh Sullivan, James Shen,
Insulin-Like Growth Factor-Binding Protein 7 Regulates Keratinocyte Proliferation, Differentiation and Apoptosis  Janna Nousbeck, Ofer Sarig, Nili Avidan,
Volume 17, Issue 2, Pages (February 2009)
Jasmine George, Minakshi Nihal, Chandra K
Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small- Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis.
Volume 18, Issue 3, Pages (March 2010)
Hui Deng, Jing Liu, Yu Deng, Gangwen Han, Yiqun G. Shellman, Steven E
Role and Regulation of STAT3 Phosphorylation at Ser727 in Melanocytes and Melanoma Cells  Masanobu Sakaguchi, Masahiro Oka, Tetsushi Iwasaki, Yasuo Fukami,
Overexpression of CRM1: A Characteristic Feature in a Transformed Phenotype of Lung Carcinogenesis and a Molecular Target for Lung Cancer Adjuvant Therapy 
B7-H3 Associated with Tumor Progression and Epigenetic Regulatory Activity in Cutaneous Melanoma  Jinhua Wang, Kelly K. Chong, Yoshitaka Nakamura, Linhda.
Presentation transcript:

Human Mitochondrial NAD(P)+–Dependent Malic Enzyme Participates in Cutaneous Melanoma Progression and Invasion  Yung-Lung Chang, Hong-Wei Gao, Chien-Ping Chiang, Wei-Ming Wang, Shih-Ming Huang, Chien-Fen Ku, Guang-Yaw Liu, Hui-Chih Hung  Journal of Investigative Dermatology  Volume 135, Issue 3, Pages 807-815 (March 2015) DOI: 10.1038/jid.2014.385 Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 1 ME1 and ME3 mRNA levels were decreased and ME2 mRNA levels were increased in melanoma compared with normal/nevi tissue in Gene Expression Omnibus (GEO) data sets. The values of ME1 (a), ME2 (b), and ME3 (c) expression levels in the microarray data sets GDS 1375 and GDS 1989, which were retrieved from the GEO. Two groups (benign and malignant) of the data were analyzed using unpaired Student’s t-test. The bars represent the 95th and 5th percentiles (*P<0.05; ***P<0.001; NS, not significant). Journal of Investigative Dermatology 2015 135, 807-815DOI: (10.1038/jid.2014.385) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 2 ME2 expression increased with melanoma tumor progression. (a) Representative hematoxylin and eosin (H&E) and immunohistochemical (IHC) staining for ME2 in human common nevi, dysplastic nevi, and malignant melanoma tissue sections. The inset is to show stained cells at lower magnification. (b) Scatter dot plot of the distribution of ME2 expression score in samples at different stages during melanoma development. (c) ME2 IHC score in acral lentiginous melanoma (ALM) and non-ALM. Inset bar=100 μm. Journal of Investigative Dermatology 2015 135, 807-815DOI: (10.1038/jid.2014.385) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 3 The effect of ME2 inhibition on melanoma cell proliferation. (a) ME1, ME2, and ME3 mRNA expression, as measured by reverse transcription–PCR in the three indicated cell lines. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a loading control. (b) Western blot analysis shows the efficacy and selectivity of the small hairpin RNA (shRNA)-lentiviral approach used to silence ME2 expression. α-Actinin was used as a loading control. (c) Cells treated with control (shCTRL) or ME2 shRNA (shME2) were seeded (2 × 104) in 24-well plates, and the cell numbers were measured at the indicated time points. (d) A2058 cells were exposed to 10 μM BrdU for an hour, and BrdU incorporation into the DNA was assayed. The marked regions were used to quantify the percentage of cells capable of BrdU incorporation, which indicated that the cells were progressing through S phase. Journal of Investigative Dermatology 2015 135, 807-815DOI: (10.1038/jid.2014.385) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 4 AMP-activated protein kinase (AMPK) activation as the mechanism for melanoma cell growth inhibition in response to ME2 depletion. (a) Silencing ME2 diminished ATP production in melanoma cells. ATP levels in A2058 cells were measured and normalized to the respective protein concentration. (b) Increased reactive oxygen species levels in A2058 ME2-knockdown cells as determined by flow cytometry using 2',7'-dichlorodihydrofluorescein diacetate (DCF). Each histogram is representative of three independent experiments. (c) Western blot analysis was used to determine the protein levels of p-AMPK (Thr172), total AMPK, acetyl Co-A carboxylase (ACC), p53, and p21. Phospho Ser-79 ACC is a biomarker of AMPK activity. (d) Western blot of p-AMPK, total AMPK, ACC, p53, and p21 in indicated melanoma cell lines transfected with control vector or with ME2-expressing vector. The level of ME2 protein after normalization with α-actinin is presented as fold change. Journal of Investigative Dermatology 2015 135, 807-815DOI: (10.1038/jid.2014.385) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 5 Cell motility and invasion were inhibited by ME2 depletion. (a) Wound healing assay of A2058 shCTRL versus shME2 cells (top) and A2058 pcDNA3 vector versus pcDNA ME2 cells (bottom) were grown to confluence and then wounded with a pipette tip. The recovered area was measured after the indicated time in serum-free medium. The statistical analysis of the relative open wound of the indicated cells (right). (b) Invasion assay of A2058 shCTRL versus shME2 cells and A2058 pcDNA3 vector versus pcDNA3 ME2 cells (top). The data are presented as mean±SD (bottom). Representative data from one of three independent assays with similar results are shown. Bar=100 μm. Journal of Investigative Dermatology 2015 135, 807-815DOI: (10.1038/jid.2014.385) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions

Figure 6 ME2 depletion reduced anchorage-independent growth and attenuated tumor growth in a xenograft model. (a) Anchorage-independent growth of ME2 knockdown and control A2058 cells in a soft agar assay. Colonies >0.1 mm were counted using ImageJ, and the data were plotted (right panel). The data are presented as the mean±SD of triplicate samples from representative data of three independent experiments. (b) The indicated A2058 cells (2 × 106) were implanted subcutaneously into right and left flanks of each immunocompromised mouse, respectively. A comparative analysis of tumor weight was performed 2 weeks after inoculation (bars, SD). The data were analyzed using the paired t-test (P=0.0025, n=9). (c) Western blot of ME2 expression in representative specimens. Journal of Investigative Dermatology 2015 135, 807-815DOI: (10.1038/jid.2014.385) Copyright © 2015 The Society for Investigative Dermatology, Inc Terms and Conditions